Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 20,000 shares at $28.96 ($579K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Seasonal sale ($579k) by Director — this insider has traded ARQT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.96 | 10,000 | $290K | 50.0% |
| 2 | $28.96 | 10,000 | $290K | 50.0% |
| Total | $28.96 avg | 20,000 | $579K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |